Updated Jul 16, 2026
Patel Sanj K has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $31.46M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | KNSA | Kiniksa Pharmaceuticals International, plc | J — Other acquisition / disposition | 900.0K | — | |
| 2026-05-01 | KNSA | Kiniksa Pharmaceuticals International, plc | S — Open-market sale | 48.6K | $54.02 | $2.62M |
| 2026-05-01 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise | 48.6K | $30.93 | $1.50M |
| 2026-04-30 | KNSA | Kiniksa Pharmaceuticals International, plc | S — Open-market sale | 2.1K | $54.01 | $116K |
| 2026-04-30 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise | 2.1K | $30.93 | $66K |
| 2026-04-30 | KNSA | Kiniksa Pharmaceuticals International, plc | S — Open-market sale | 22.5K | $54.01 | $1.22M |
| 2026-04-30 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise | 22.5K | $30.93 | $697K |
| 2026-04-30 | KNSA | Kiniksa Pharmaceuticals International, plc | S — Open-market sale | 51.8K | $54.02 | $2.80M |
| 2026-04-30 | KNSA | Kiniksa Pharmaceuticals International, plc | S — Open-market sale | 243.6K | $52.02 | $12.67M |
| 2026-04-30 | KNSA | Kiniksa Pharmaceuticals International, plc | S — Open-market sale | 113.7K | $51.47 | $5.85M |
| 2026-04-30 | KNSA | Kiniksa Pharmaceuticals International, plc | S — Open-market sale | 74.6K | $50.43 | $3.76M |
| 2026-04-30 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise | 51.8K | $30.93 | $1.60M |
| 2026-04-30 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise | 431.9K | $10.36 | $4.47M |
| 2026-04-08 | KNSA | Kiniksa Pharmaceuticals International, plc | F — Tax withholding / forfeiture [10b5-1] | 4.8K | $48.94 | $236K |
| 2026-04-08 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise [10b5-1] | 10.0K | — | |
| 2026-04-08 | KNSA | Kiniksa Pharmaceuticals International, plc | S — Open-market sale [10b5-1] | 7.3K | $50.01 | $364K |
| 2026-04-08 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise [10b5-1] | 7.3K | $10.36 | $75K |
| 2026-04-03 | KNSA | Kiniksa Pharmaceuticals International, plc | F — Tax withholding / forfeiture | 10.3K | $48.13 | $496K |
| 2026-04-03 | KNSA | Kiniksa Pharmaceuticals International, plc | M — Option exercise | 21.3K | — | |
| 2025-09-01 | KNSA | Kiniksa Pharmaceuticals International, plc | F — Tax withholding / forfeiture | 3.2K | $34.28 | $109K |
Patel Sanj K is a corporate insider — currently tracked as Insider of Kiniksa Pharmaceuticals International, plc (KNSA). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 9 open-market sales ($31.46M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Patel Sanj K profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.